Multi-omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited-stage small cell lung cancer to definitive chemoradiotherapy
机构：[1]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.[2]Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.[3]Department of Oncology, Second People's Hospital of Yibin City, Yibin, Sichuan, China.[4]Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.[5]Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan, China.河南省肿瘤医院
This study was supported in part by the National
Natural Science Foundation of China (NSFC82073345), the
Natural Science Foundation of Shandong Province Innovation
and Development Joint Fund (ZR202209010002),
the Taishan Scholars Programand Jinan Clinical Medicine
Science and Technology Innovation Plan (202019060) to
Shuanghu Yuan and the Major Basic Research Program
of the National Natural Science Foundation of Shandong(
ZR2022ZD16), Natural Science Youth Foundation
of Shandong (ZR2023QH155), and Postdoctoral Science
Foundation of China (2023M742159) to Li Li.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类|1 区医学
小类|2 区医学：研究与实验2 区肿瘤学
第一作者：
第一作者机构：[1]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
通讯作者：
通讯机构：[1]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.[5]Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan, China.
推荐引用方式(GB/T 7714)：
Li Li,Duan Jinghao,Gao Yongsheng,et al.Multi-omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited-stage small cell lung cancer to definitive chemoradiotherapy[J].Clinical And Translational Medicine.2024,14(1):e1522.doi:10.1002/ctm2.1522.
APA：
Li Li,Duan Jinghao,Gao Yongsheng,Yin Ying,Yang Fengchang...&Yuan Shuanghu.(2024).Multi-omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited-stage small cell lung cancer to definitive chemoradiotherapy.Clinical And Translational Medicine,14,(1)
MLA：
Li Li,et al."Multi-omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited-stage small cell lung cancer to definitive chemoradiotherapy".Clinical And Translational Medicine 14..1(2024):e1522
